Evidence map›Paper›PMID 16681859›Full record

ArticleMolecular pain2006

Enhanced group II mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala.

Jeong S Han, Yu Fu, Gary C Bird, Volker Neugebauer

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Advances in translating mGluPharmacology, biochemistry, and behavior · 2022
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Amygdala pain mechanisms.Handbook of experimental pharmacology · 2015
    Review
  13. Article
  14. The amygdala between sensation and affect: a role in pain.Journal of molecular psychiatry · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. Forebrain pain mechanisms.Brain research reviews · 2009
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeong S HanDepartment of Neuroscience and Cell Biology, The University of Texas Medical Branch, Galveston, Texas 77555-1069, USA. jshan@utmb.edu
Yu Fu
Gary C Bird
Volker Neugebauer
The University of Texas Medical Branch at Galveston · US

Funding

VISCERAL PAINP01NS011255 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI NEUGEBAUER, VOLKER · 1985 to 2012
$13.6M
PAIN, NOCICEPTION, AND THE AMYGDALAR01NS038261 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Volker Neugebauer, Igor Ponomarev · 1999 to 2026
$8.7M
NINDS NIH HHS NS11255NINDS NIH HHS NS38261NINDS NIH HHS P01 NS011255NINDS NIH HHS R01 NS038261
6 · The paper itself

Abstract

backgroundThe latero-capsular part of the central nucleus of the amygdala (CeLC) is the target of the spino-parabrachio-amygdaloid pain pathway. Our previous studies showed that CeLC neurons develop synaptic plasticity and increased neuronal excitability in the kaolin/carrageenan model of arthritic pain. These pain-related changes involve presynaptic group I metabotropic glutamate receptors (mGluRs) and postsynaptic NMDA and calcitonin gene-related peptide (CGRP1) receptors. Here we address the role of group II mGluRs.

resultsWhole-cell current- and voltage-clamp recordings were made from CeLC neurons in brain slices from control rats and arthritic rats (>6 h postinjection of kaolin/carrageenan into the knee). Monosynaptic excitatory postsynaptic currents (EPSCs) were evoked by electrical stimulation of afferents from the pontine parabrachial (PB) area. A selective group II mGluR agonist (LY354740) decreased the amplitude of EPSCs more potently in CeLC neurons from arthritic rats (IC50 = 0.59 nM) than in control animals (IC50 = 15.0 nM). The inhibitory effect of LY354740 was reversed by a group II mGluR antagonist (EGLU) but not a GABAA receptor antagonist (bicuculline). LY354740 decreased frequency, but not amplitude, of miniature EPSCs in the presence of TTX. No significant changes of neuronal excitability measures (membrane slope conductance and action potential firing rate) were detected.

conclusionOur data suggest that group II mGluRs act presynaptically to modulate synaptic plasticity in the amygdala in a model of arthritic pain.

Indexed as

AmygdalaAnimalsArthritis, ExperimentalBridged Bicyclo CompoundsExcitatory Amino Acid AgonistsGlutamatesMaleNeuronal PlasticityPainRatsRats, Sprague-DawleyReceptors, Metabotropic GlutamateSynaptic PotentialsSynaptic Transmissionalpha-ethylglutamic acidBridged Bicyclo CompoundseglumetadExcitatory Amino Acid AgonistsGlutamatesReceptors, Metabotropic Glutamate

Identifiers

PMID16681859
PMCPMC1471776
OpenAlexW1577753627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.